Methenamine Hippurate is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Aurobindo Pharma Limited. The primary component is Methenamine Hippurate.
Product ID | 65862-782_02aef0dc-38e3-48ae-9d4f-0e28829750d5 |
NDC | 65862-782 |
Product Type | Human Prescription Drug |
Proprietary Name | Methenamine Hippurate |
Generic Name | Methenamine Hippurate |
Dosage Form | Tablet |
Route of Administration | ORAL |
Marketing Start Date | 2016-07-05 |
Marketing Category | ANDA / ANDA |
Application Number | ANDA205661 |
Labeler Name | Aurobindo Pharma Limited |
Substance Name | METHENAMINE HIPPURATE |
Active Ingredient Strength | 1 g/1 |
NDC Exclude Flag | N |
Listing Certified Through | 2019-12-31 |
Marketing Start Date | 2016-07-05 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | ANDA |
Application Number | ANDA205661 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2016-07-05 |
Ingredient | Strength |
---|---|
METHENAMINE HIPPURATE | 1 g/1 |
SPL SET ID: | 9f002ad9-58e7-44f2-a980-3cc3f36bbd9b |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
0115-1754 | Methenamine Hippurate | Methenamine Hippurate |
0955-1037 | Methenamine Hippurate | Methenamine Hippurate |
42571-332 | Methenamine Hippurate | Methenamine Hippurate |
43199-020 | Methenamine Hippurate | Methenamine Hippurate |
47781-577 | Methenamine Hippurate | Methenamine Hippurate |
50268-549 | Methenamine Hippurate | Methenamine Hippurate |
50742-142 | METHENAMINE HIPPURATE | methenamine hippurate |
60687-694 | Methenamine Hippurate | Methenamine Hippurate |
64720-139 | Methenamine Hippurate | Methenamine Hippurate |
65862-782 | Methenamine Hippurate | Methenamine Hippurate |
68151-0984 | Methenamine Hippurate | Methenamine Hippurate |
69315-210 | Methenamine Hippurate | Methenamine Hippurate |
30698-277 | HIPREX | Methenamine Hippurate |
30698-477 | HIPREX | Methenamine Hippurate |